The TeamConnor Childhood Cancer Foundation announced a new nationwide event, “Swing Fore Childhood Cancer,” presented by Northwestern Mutual.
The fundraising event will be held from 4 to 6 p.m., Thursday, Sept. 28.
Hosted during Childhood Cancer Awareness Month, the fundraiser will be held at Topgolf and Suite Shots locations across the nation, including Texas, California, Louisiana, Florida, Maryland, New Jersey, North Dakota, and Tennessee. Registration is now open to the public in all markets.
“The goal of “Swing Fore Kids Childhood Cancer is to further spread awareness of our mission,” Tait Cruse, managing partner of Northwestern Mutual’s Dallas locations, co-founder of TeamConnor Childhood Cancer Foundation and father to Connor Cruse, said in a statement.
Cruse says the event will raise “much-needed funds to expand important pediatric cancer research and childhood cancer clinical trials.”
Money raised will benefit a local children’s hospital in that market, according to the TeamConnor co-founder.
Childhood cancer is the leading cause of death by disease in children under the age of 15 in the nation, according to The National Children’s Cancer Society. Each year in the United States, an estimated 15,780 children aged 0-19 are diagnosed with cancer.
That’s 43 children per day being told they have cancer—yet less than 4% of the federal government’s budget for cancer research is dedicated to childhood cancers, the foundation said.
Event details
Topgolf locations in North Texas staging the event are:
THE COLONY
3760 Blair Oaks Drive, The Colony, TX 75056
Benefitting Children’s Health/UT Southwestern
FORT WORTH
2201 E 4th St., Fort Worth, TX 76102
Benefitting Cook Children’s
TeamConnor was founded in 2008 by Connor Cruse’s parents, Joy and Tait Cruse.
Connor was 4 years old when he was diagnosed with Stage IV neuroblastoma on May 15, 2005. He waged a four-year battle that included more than 200 nights in the hospital, 14 surgeries, 40 blood transfusions, 25 rounds of chemo, two bone marrow transplants, and countless painful procedures, the foundation said.
Since 2008, TeamConnor has donated nearly $5 million to numerous hospitals nationwide in its mission to fund improved treatment options and ultimately cures for childhood cancers.
For more information on how to join the fight against childhood cancer, you can visit the TeamConnor website here.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The 29 new grants approved by CPRIT's Oversight Committee include the first CPRIT Scholar award to Southern Methodist University in Dallas and state funding for Dallas' Baylor Research Institute to join a major National Cancer Institute study.
-
The Cancer Prevention and Research Institute of Texas approved over $90 million in new cancer research and prevention grants at its quarterly meeting near the Texas Capitol on Wednesday—and $20.6 million of that money is coming to North Texas to advance everything from breast cancer and lung cancer screening to "deep learning models" to facilitate T-cell receptor therapies.
-
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
-
Dr. Ahn is working on something very small that may have a profound, lifesaving impact on something hugely dangerous. In collaboration with UTSW Medical Center professor Dr. Ganesh Raj and UTHSC San Antonio's Ratna Vadlamudi, Ahn has created a molecule that can kill an array of cancers, including an aggressive form of breast cancer. The goal of the molecules is to prevent molecular “handshakes” between proteins that can cause out-of-control cell growth that spreads cancer further.
-
Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients. Lung cancer is the most lethal form of cancer with the highest mortality rate, according to the biotech, which aims to improve the treatment of cancer with its tumor-directed technology. There were an estimated 1.8 million deaths globally and around 2.2 million new cases by the end of 2020 alone, it said, citing GLOBOCAN statistics. Preliminary results are encouraging, the biotech reports. The tech-based particle delivery of the chemotherapy drug—known…
